Decision On Covaxin Clearance Next Week, Says WHO

Covaxin's manufacturer Bharat Biotech "has been submitting data to WHO on a rolling basis and submitted additional info at WHO's request on 27 September", a tweet read.

The World Health Organisation will likely decide on granting Emergency Use Listing to Covaxin - India's indigenously developed vaccine against coronavirus - next week. This comes almost a week after the UN body delayed the emergency use authorisation (EUA) for India's indigenously developed vaccine as the global body sent more technical queries to its manufacturer Bharat Biotech.

"WHO & an independent group of experts are scheduled to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin," the United Nations agency for international public health said in a series of tweets.

Bharat Biotech, the manufacturer of the vaccine, "has been submitting data to the WHO on a rolling basis and submitted additional info at WHO's request on 27 September", another tweet read.

"WHO experts are currently reviewing this info and if it addresses all questions raised, the WHO assessment will be finalised next week," the tweet said.